AlphaCrest Capital Management’s ICU Medical ICUI Stock Holding History

AlphaCrest Capital Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,328	Closed	-$383K	–	1318
2022 Q2	$383K	Sell	2,328 -2,120	-48%	-$408K	0.02%	1037
2022 Q1	$990K	Sell	4,448 -1,247	-22%	-$279K	0.06%	549
2021 Q4	$1.35M	Buy	5,695 +4,201	+281%	+$981K	0.05%	646
2021 Q3	$349K	Sell	1,494 -1,025	-41%	-$215K	0.02%	1046
2021 Q2	$518K	Buy	2,519 +993	+65%	+$204K	0.02%	947
2021 Q1	$314K	Buy	+1,526	New	+$322K	0.02%	1008
2020 Q4	–	Sell	-1,305	Closed	-$239K	–	1190
2020 Q3	$239K	Buy	+1,305	New	+$246K	0.03%	976

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AlphaCrest Capital Management's ICUI Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of ICU Medical (ICUI) in Q3 2022, closing a stake of 2,328 shares — an estimated $383K sold.

AlphaCrest Capital Management first reported a position in ICUI in Q3 2020 and held it in 7 quarters. The position peaked at $1.35M in Q4 2021. 243 funds tracked by Wall St. Rank hold ICUI as of Q3 2022.

AlphaCrest Capital Management reported no remaining ICU Medical position as of Q3 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 2,328 ICU Medical shares in Q3 2022, an estimated $383K.
AlphaCrest Capital Management first reported a position in ICU Medical in Q3 2020 and held it in 7 quarters.
AlphaCrest Capital Management's ICU Medical position peaked at $1.35M in Q4 2021.
243 funds tracked by Wall St. Rank held ICU Medical as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.